You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》醫脈通(02192.HK)今日起招股 入場費13,737.05元
阿思達克 06-30 09:02
中國在線醫師平台醫脈通(02192.HK)於全球發行1.55億股,其中1,551萬股於本港公開發售,今日起招股,招股價介乎24.1元至27.2元,每手500股,入場費13,737.05元。下周三(7月7日)截止招股,預期同日定價,7月15日掛牌上市。聯席保薦人為高盛及海通國際,聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人為高盛、海通國際及中金公司。

公司已與七名基石投資者訂立協議,投資額合共2.2億美元,其中FMR、富達國際、騰訊(00700.HK)全資附屬Tencent Mobility及GIC各自認購4,000萬美元,Matthews Funds、Springhill及OrbiMed Funds分別認購2,000萬美元。

以招股價中位數25.65元計算,公司預期集資淨額為37.71億元,其中40%擬用於在未來三至五年內擴展業務,包括開發及增加解決方案種類、擴闊客戶基礎、提高客戶忠誠度及促進用戶增長與參與度。另外30%擬用於在未來三至五年內投資技術及提高研發能力,20%擬用於挑選戰略投資或收購機會,其餘10%擬用作一般補充營運資金及其他一般企業用途。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account